Sort   by:  
 Page size 
UnknownPrediction of week 4 virological response in hepatitis C for making decision on triple therapy: the Optim study.
Not available
S-EPMC4426774 | biostudies-literature
UnknownThe biochemical pattern defines MASLD phenotypes linked to distinct histology and prognosis.
Not available
S-EPMC11217049 | biostudies-literature
UnknownValidation of BMP8A fibrosis score to identify patients with metabolic dysfunction-associated steatohepatitis with advanced liver fibrosis.
Not available
S-EPMC12628818 | biostudies-literature
UnknownPhylogeny and Phylogeography of a Recent HIV-1 Subtype F Outbreak among Men Who Have Sex with Men in Spain Deriving from a Cluster with a Wide Geographic Circulation in Western Europe.
Not available
S-EPMC4658047 | biostudies-literature
UnknownSilencing hepatic MCJ attenuates non-alcoholic fatty liver disease (NAFLD) by increasing mitochondrial fatty acid oxidation.
Not available
S-EPMC7334216 | biostudies-literature
UnknownFibroblast growth factor 21 is a hepatokine involved in MASLD progression.
Not available
S-EPMC11485537 | biostudies-literature
UnknownObesity-dependent metabolic signatures associated with nonalcoholic fatty liver disease progression.
Not available
S-EPMC3321123 | biostudies-literature
UnknownIncidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study.
Not available
S-EPMC8268420 | biostudies-literature
UnknownCIBERER: Spanish national network for research on rare diseases: A highly productive collaborative initiative.
Not available
S-EPMC9305285 | biostudies-literature
UnknownMortality after surgery in Europe: a 7 day cohort study.
Not available
S-EPMC3493988 | biostudies-literature
Sort   by:  
 Page size